TOGETHER, FOR CHANGE

• 来源期刊: 北京周报（英文版）
• 年，卷（期）: 2022,（15）
• 所属期刊栏目: COVER STORY
• 页码范围: 20-21
• 页数: 2页
• 语种: 英文
• DOI: 10.3969/j.issn.1000-9140.2022.15.007

摘要

Leon Wang, Executive Vice President, International and China President of AstraZeneca AstraZeneca entered China in 1993 and has since invested over $1 billion in production and operation along with an additional $1.5 billion in research and development (R&D) here. In Wuxi, Jiangsu Province, we have established a distribution center to export medicines to over 70 countries and regions. Today, China has devel-oped into AstraZeneca's second largest market worldwide, following the U.S., and we are one of the best-performing foreign pharmaceutical companies in the Chinese market.